Good morning, everyone, and how are you today? Gloomy skies are hovering over the Pharmalot corporate campus again. Nonetheless, our spirits remain sunny. You know the refrain: 'Every brand new day should be unwrapped like a precious gift.' In other words, those meetings and deadlines may loom, but you will persevere. Meanwhile, please join us for, yes, that mandatory cup of stimulation and get ready to conquer the world. Have a good one and stay in touch...
Merck Returns Blood Clot Drug to Portola (Reuters)
Bayer Launches Melt-In-The-Mouth Impotence Pill In UK (Pharma Times)
Abbott Settles HIV Drug Price Lawsuit With Pharmacies (Reuters)
No Fracture Warnings Needed On OTC Heartburn Meds (Reuters)
Canadian Access To Medicines Bill Stalls In Senate (Bridges Weekly)
Amgen Says Prolia Increases Bone Density Over Time (Reuters)
Protalix Plans Tests Of Fabry Drug (Bloomberg News)
Bristol-Myers Melanoma Drug May Be Approved This Week (Reuters)
UK Gov't Offers Plan To Boost Life Sciences (Pharma Times)